CorMedix (CRMD) Preferred Shares (2013 - 2025)
CorMedix (CRMD) posted Preferred Shares of $92.0 for Q3 2025, little changed sequentially from $92.0 in Q2 2025, and down 49.45% YoY from $182.0 in Q3 2024.
CorMedix (CRMD) Preferred Shares (2013 - 2025) Analysis & Trends
CorMedix has reported Preferred Shares for 12 years, with the latest figure at $92.0 in Q3 2025.
- Quarterly Preferred Shares fell 49.45% year-over-year to $92.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $92.0 (down 49.45% YoY) and the FY2024 annual result came in at $137.0, down 24.73% from the prior year.
- Preferred Shares was little changed at $92.0 in Q3 2025 per CRMD's latest filing, from $92.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $182.0 in Q1 2021 and troughed at $92.0 in Q1 2025.
- A 5-year average of $165.42 and a median of $182.0 in 2021 frame the typical range for Preferred Shares.
- The sharpest annual moves came in 2022 and 2025: Preferred Shares changed 0.0% in 2022, then sank 49.45% in 2025.
- Over 5 years, Preferred Shares stood at $182.0 in 2021, then changed by 0.0% to $182.0 in 2022, then changed by 0.0% to $182.0 in 2023, then retreated by 24.73% to $137.0 in 2024, then slumped by 32.85% to $92.0 in 2025.
- According to Business Quant data, Preferred Shares over the past three periods registered $92.0, $92.0, and $92.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 92.00 |
| Jun 30, 2025 | 92.00 |
| Mar 31, 2025 | 92.00 |
| Dec 31, 2024 | 137.00 |
| Sep 30, 2024 | 182.00 |
| Jun 30, 2024 | 182.00 |
| Mar 31, 2024 | 182.00 |
| Dec 31, 2023 | 182.00 |
| Sep 30, 2023 | 182.00 |
| Jun 30, 2023 | 182.00 |
| Mar 31, 2023 | 182.00 |
| Dec 31, 2022 | 182.00 |
| Sep 30, 2022 | 182.00 |
| Jun 30, 2022 | 182.00 |
| Mar 31, 2022 | 182.00 |
| Dec 31, 2021 | 182.00 |
| Sep 30, 2021 | 182.00 |
| Jun 30, 2021 | 182.00 |
| Mar 31, 2021 | 182.00 |
| Dec 31, 2020 | 242.00 |